Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 4Terminated 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 5Rectal Neoplasms 3Esophageal Squamous Cell Carcinoma 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Waldenstrom Macroglobulinemia 1Triple Negative Breast Neoplasms 1Stress, Psychological 1Stomach Neoplasms 1Stage III and IV Ovarian Cancer 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Pathologic Complete Response 1Pancreatic Neoplasms 1Osteosarcoma 1Neoplasm, Residual 1Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer 1NSCLC 1Muscle-Invasive Bladder Carcinoma 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Locally Advanced Cervical Cancer 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Carcinoma, Ovarian Epithelial 1Bites and Stings 1Anxiety Disorders 1

Interventions

surufatinib 1irinotecan sucrosofate 1envafolimab 1anlotinib 1Vincristine 1Temozolomide 1Proton Therapy 1Positron Emission Tomography Computed Tomography 1Neoadjuvant Therapy 1Methotrexate 1Ifosfamide 1Etoposide 1Epirubicin 1Drug Therapy 1Brachytherapy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Osteosarcoma × Neoadjuvant Therapy × Clear all
NCT07142863 2025-08-27

Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable Osteosarcoma Patients

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2 Not yet recruiting
23 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡